2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
14
Lung Neoplasms
10
Breast Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Stomach Neoplasms
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Wilms Tumor
1
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Interventions
Metformin
10
Clomiphene
10
Inositol
3
Medroxyprogesterone Acetate
2
Letrozole
2
Glycoprotein Hormones, alpha Subunit
2
Folic Acid
2
Chorionic Gonadotropin
2
salicylsalicylic acid
1
maltodextrin
1
Vitamin D
1
Ultrasonography
1
Sodium Salicylate
1
Raloxifene Hydrochloride
1
Progestins
1
Progesterone
1
Nimodipine
1
Lactalbumin
1
Inulin
1
Hematologic Tests
1
Flutamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anovulation
×
Hematologic Tests
×
Clear all
NCT05926115
2023-07-03
PEP-Colombia
Instituto de fertilidad humana, InSer
Unknown
626 enrolled